Pazdernik V

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States of America.

3 papers

ArticleKetamine

Utilizing depression symptom-based phenotypes to explore ketamine treatment response in major depression: The Bio-K multicenter trial.

Penaluna BK, Vande Voort JL, Bobo WV +7

Europe PMC2025
ArticleKetamine

Hypersomnia as a predictor of response to intravenous ketamine/intranasal esketamine in treatment resistant depression.

Patarroyo-Rodriguez L, Pazdernik V, Vande Voort JL +2

Europe PMC2024
ArticleKetamine

Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study.

Singh B, Kung S, Pazdernik V +5

Europe PMC2023